More information: Yi-Zong Lee et al, Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus, Nature Communications (2024). DOI: 10. ...

Each year, RSV results in millions of outpatient visits for young children, tens of thousands of hospitalizations among children and adults aged 65 and older, and thousands of deaths. This winter ...

New research discussed the structure and life cycle of respiratory syncytial virus (RSV), the current research on the treatment and prevention of RSV infections, and the advancements in RSV mRNA ...

It is estimated that in 2019, RSV caused 5.2 million cases of acute respiratory infection, 470,000 hospitalizations, and 33,000 in-hospital deaths in adults 60 years of age and older in ...

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalisation among young children worldwide and each year, ... change in age structure and less severe illness ...

Respiratory Syncytial Virus (RSV) is a major health concern affecting millions each year. From the first sniffle to serious complications, understanding RSV is crucial, especially for vulnerable ...

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, ...

Respiratory syncytial virus (RSV) is a common germ that can infect the nose, throat, lungs, and breathing passages. For most healthy children and adults, RSV can result in mild, cold-like symptoms.